UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 214

Sortiert nach

Nutrient-derived modification of mineral corticoid receptors is relevant to diabetic kidney disease progression

Hypertension research, 2023-01, Vol.46 (1), p.261-263

Kanasaki, Keizo

2023

Volltextzugriff (PDF)

N‐acetyl‐seryl‐aspartyl‐lysyl‐proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects

Journal of diabetes investigation, 2020-05, Vol.11 (3), p.516-526

Kanasaki, Keizo

2020

Volltextzugriff (PDF)

Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy

Nature communications, 2021-04, Vol.12 (1), p.2368-15, Article 2368

2021

Volltextzugriff (PDF)

The Role of Autophagy in the Pathogenesis of Diabetic Nephropathy

Journal of Diabetes Research, 2013-01, Vol.2013, p.193757-9

2013

Volltextzugriff (PDF)

Concerted efforts to combat diabetic complications

Kidney international, 2016-02, Vol.89 (2), p.269-271

Kanasaki, Keizo

2016

Volltextzugriff (PDF)

Uncoupling of VEGF with Endothelial NO as a Potential Mechanism for Abnormal Angiogenesis in the Diabetic Nephropathy

Journal of diabetes research, 2013-01, Vol.2013, p.184539-7

2013

Volltextzugriff (PDF)

Sodium–glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells

Diabetes & metabolism, 2020-10, Vol.46 (5), p.353-361

2020

Volltextzugriff (PDF)

Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease

Clinical and experimental nephrology, 2013-08, Vol.17 (4), p.488-497

2013

Volltextzugriff (PDF)

The impact of micronutrient deficiency on pregnancy complications and development origin of health and disease

The journal of obstetrics and gynaecology research, 2021-06, Vol.47 (6), p.1965-1972

2021

Volltextzugriff (PDF)

Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen

Diabetes (New York, N.Y.), 2014-06, Vol.63 (6), p.2120-2131

2014

Volltextzugriff (PDF)

The PKM2 activator TEPP‐46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF‐1α accumulation

Journal of diabetes investigation, 2021-05, Vol.12 (5), p.697-709

2021

Volltextzugriff (PDF)

Biology of obesity: lessons from animal models of obesity

BioMed research international, 2011-01, Vol.2011 (1), p.197636

2011

Volltextzugriff (PDF)

Cancer biology in diabetes update: Focusing on antidiabetic drugs

Journal of diabetes investigation, 2024-05, Vol.15 (5), p.525-540

2024

Volltextzugriff (PDF)

Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition

Kidney international, 2015-09, Vol.88 (3), p.479-489

2015

Volltextzugriff (PDF)

Metabolic reprogramming by N‐acetyl‐seryl‐aspartyl‐lysyl‐proline protects against diabetic kidney disease

British journal of pharmacology, 2020-08, Vol.177 (16), p.3691-3711

2020

Volltextzugriff (PDF)

Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study

Journal of diabetes investigation, 2023-12, Vol.14 (12), p.1341-1343

2023

Volltextzugriff (PDF)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis

Frontiers in endocrinology (Lausanne), 2013, Vol.4, p.7-7

2013

Volltextzugriff (PDF)

MG132 Ameliorates Kidney Lesions by Inhibiting the Degradation of Smad7 in Streptozotocin-Induced Diabetic Nephropathy

Journal of Diabetes Research, 2014-01, Vol.2014, p.918396-8

2014

Volltextzugriff (PDF)

Editorial: Receptor Biology and Cell Signaling in Diabetes

Frontiers in pharmacology, 2022-03, Vol.13, p.864117-864117

2022

Volltextzugriff (PDF)

The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin

Clinical science (1979), 2018-02, Vol.132 (4), p.489

Kanasaki, Keizo

2018

Volltextzugriff (PDF)

Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4), p.735-746

2019

Volltextzugriff (PDF)

AMP-Activated Protein (AMPK) in Pathophysiology of Pregnancy Complications

International journal of molecular sciences, 2018-10, Vol.19 (10), p.3076

2018

Volltextzugriff (PDF)

Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high‐fat diet

Journal of diabetes investigation, 2018-09, Vol.9 (5), p.1025-1032

2018

Volltextzugriff (PDF)

CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology

Cancers, 2021-05, Vol.13 (9), p.2191

2021

Volltextzugriff (PDF)

MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT

BioMed research international, 2013-01, Vol.2013, p.125469-10

2013

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(203)

Publikationsform

Artikel
(210)
Berichte
(4)

Sprache

Englisch
(200)
Japanisch
(88)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Nutrient-derived modification of mineral corticoid receptors is relevant to diabetic kidney disease progression

N‐acetyl‐seryl‐aspartyl‐lysyl‐proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects

Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy

The Role of Autophagy in the Pathogenesis of Diabetic Nephropathy

Concerted efforts to combat diabetic complications

Uncoupling of VEGF with Endothelial NO as a Potential Mechanism for Abnormal Angiogenesis in the Diabetic Nephropathy

Sodium–glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells

Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease

The impact of micronutrient deficiency on pregnancy complications and development origin of health and disease

Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen

The PKM2 activator TEPP‐46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF‐1α accumulation

Biology of obesity: lessons from animal models of obesity

Cancer biology in diabetes update: Focusing on antidiabetic drugs

Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition

Metabolic reprogramming by N‐acetyl‐seryl‐aspartyl‐lysyl‐proline protects against diabetic kidney disease

Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis

MG132 Ameliorates Kidney Lesions by Inhibiting the Degradation of Smad7 in Streptozotocin-Induced Diabetic Nephropathy

Editorial: Receptor Biology and Cell Signaling in Diabetes

The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin

Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis

AMP-Activated Protein (AMPK) in Pathophysiology of Pregnancy Complications

Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high‐fat diet

CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology

MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT

Suchergebnisse filtern